Acumen Pharmaceuticals (ABOS) Accumulated Expenses (2022 - 2026)
Acumen Pharmaceuticals' Accumulated Expenses was $7.53 million in Q2 2026, down 35.3% from $11.65 million a year earlier but up 43.0% from the prior quarter.
Powered by 
Analysis
Acumen Pharmaceuticals (ABOS) Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Accumulated Expenses at Acumen Pharmaceuticals came in at $10.07 million, up 52.3% from FY2024.
- Accumulated Expenses has now increased for three consecutive years, with a three-year compound annual growth rate of 44.3% (FY2022 to FY2025).
- In earlier years, Accumulated Expenses was $6.62 million in FY2024 (+2.6%), $6.45 million in FY2023 (+92.5%) and $3.35 million in FY2022.
- Quarterly Accumulated Expenses has moved between $2.37 million (Q2 2023) and $11.65 million (Q2 2025) over five years.
- Compared with a year earlier, Accumulated Expenses was higher in six of the last eight quarters, with growth averaging 54.2%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q2 2025 (growth of 191.0%); the worst was Q2 2026 (a decline of 35.3%).
- Per Business Quant data, ABOS's Accumulated Expenses in the three quarters before Q2 2026 was $5.27 million (Q1 2026), $10.07 million (Q4 2025) and $7.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Acumen Pharmaceuticals | 148.11 Mn | -333.96 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.53 Mn |
| Mar 31, 2026 | 5.27 Mn |
| Dec 31, 2025 | 10.07 Mn |
| Sep 30, 2025 | 7.79 Mn |
| Jun 30, 2025 | 11.65 Mn |
| Mar 31, 2025 | 6.71 Mn |
| Dec 31, 2024 | 6.62 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 2.91 Mn |
| Dec 31, 2023 | 6.45 Mn |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 2.37 Mn |
| Dec 31, 2022 | 3.35 Mn |
API Access
Acumen Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ABOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ABOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ABOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();